IE
RVMD icon

Israel Englander’s Revolution Medicines RVMD Stock Holding History

Israel Englander’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
+2,300
New +$336K ﹤0.01% 4891
2024
Q1 		– Sell
-71,200
Closed -$2.04M – 6575
2023
Q4 		$2.04M Buy
+71,200
New +$1.71M ﹤0.01% 3587
2023
Q3 		– Sell
-30,000
Closed -$803K – 6497
2023
Q2 		$803K Buy
+30,000
New +$736K ﹤0.01% 4208
2022
Q4 		– Sell
-50,100
Closed -$988K – 6980
2022
Q3 		$988K Buy
+50,100
New +$1.1M ﹤0.01% 4357

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Israel Englander's RVMD Position: Q2 2026 in Review

Israel Englander reduced its Revolution Medicines (RVMD) stake by 43% in Q2 2026, selling an estimated $23.5M and leaving 216,208 shares worth $40.5M. The position accounts for 0.01% of the portfolio, ranked #1031.

Israel Englander first reported a position in RVMD in Q1 2020 and has held it in 21 quarters since. The position peaked at $63.7M in Q4 2025. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Israel Englander held 216,208 shares of Revolution Medicines worth $40.5M as of Q2 2026.
  • Israel Englander sold 161,124 Revolution Medicines shares in Q2 2026, an estimated $23.5M.
  • Revolution Medicines made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1031 holding.
  • Israel Englander first reported a position in Revolution Medicines in Q1 2020 and has held it in 21 quarters since.
  • Israel Englander's Revolution Medicines position peaked at $63.7M in Q4 2025.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.